Skip to main content
. 2022 Feb 18;17(9):e202100755. doi: 10.1002/cmdc.202100755

Table 2.

HDAC inhibition and physicochemical properties of full‐sized inhibitors 10 ac.

graphic file with name CMDC-17-0-g007.jpg

R1

Physicochemical Properties

IC50 [nM]

LogD7.4

Solubility[a,e] [μg/mL]

HDAC1[b,e]

HDAC2[b,e]

HDAC3[b,e]

HDAC6[c,e]

10 a

graphic file with name CMDC-17-0-g014.jpg

3.16

0.21±0.03

41.8±0.2

100.2±2.6

>6,666[d]

>10,000[d]

10 b

graphic file with name CMDC-17-0-g010.jpg

2.68

1.99±0.04

41.1±3.7

85.5±11.6

>3,333[d]

>10,000[d]

10 c

graphic file with name CMDC-17-0-g026.jpg

2.29

7.48±0.33

26.2±0.9

59.3±7.9

16,820±2,515

>10,000[d]

VK‐1

3.19

0.98±0.10

68.6±10.4

128.2±14.5

310.4±7.8

>10,000[d]

entinostat

n.d.

n.d.

426.1±58.7

354.0±43.1

310.5±9.8

>10,000[d]

vorinostat

0.99

255±3.71

113.0±16.9

191.4±15.4

109.5±9.7

21.7±3.2

[a] PBS buffer, pH=7.4; [b] preincubation of enzyme and inhibitor 1 h at 25 °C; [c] preincubation of enzyme and inhibitor 15 min at 25 °C; [d] <25 % inhibition at stated concentration; n.d.: not determined, [e] mean ±SD, at least two independent experiments.